Actualités - IntegraGen

IN THE NEWS

INTEGRAGEN AND BIOASTER SIGN PARTNERSHIP AGREEMENT IN GENOMICS AND TRANSCRIPTOMICS

20 January 2022

IntegraGen and BIOASTER have been collaborating for several years on genomic and transcriptomic analyses. Driven by the desire to strengthen this relationship, the two entities have entered into a... Read More
INTEGRAGEN SUPPORTS THE ANTOINE LACASSAGNE CENTER IN NICE FOR A LARGE-SCALE RESEARCH PROJECT ON COLORECTAL CANCER PATIENTS

June 25, 2021

Founded in 1961, the Centre Antoine Lacassagne is one of the 18 Cancer Centers in the UNICANCER network in France. The Center's mission is to... Read More
NEW LOOK. NEW PORTFOLIO. NEW OPPORTUNITIES.

June 17, 2021

FOLLOWING ITS ACQUISITION BY ONCODNA, INTEGRAGEN HAS UNDERGONE A COMPLETE OVERHAUL AND IS NOW READY TO EMBARK ON NEW PROJECTS IN THE FIELDS OF CANCER AND... Read More

INTEGRAGEN SUPPORTS THE ANTOINE LACASSAGNE CENTER IN NICE FOR A LARGE-SCALE RESEARCH PROJECT ON COLORECTAL CANCER PATIENTS

June 25, 2021

Founded in 1961, the Centre Antoine Lacassagne is one of 18 cancer centers... Read More
NEW LOOK. NEW PORTFOLIO. NEW OPPORTUNITIES.

June 17, 2021

FOLLOWING ITS ACQUISITION BY ONCODNA, INTEGRAGEN HAS UNDERGONE A COMPLETE OVERHAUL AND IS NOW... Read More
POTENTIAL INVOLVEMENT OF URINARY TRACT INFECTIONS IN THE DEVELOPMENT OF BLADDER CANCER

15 March 2021

Uropathogenic E.coli induces DNA damage in the bladder As provider of the whole genome sequencing, IntegraGen... Read More
NEW PERSPECTIVES IN THE DIAGNOSIS AND TREATMENT OF DUCHENNE MUSCULAR DYSTROPHY

3 March 2021

Myogenesis modelled by human pluripotent stem cells: a multi-omic study of Duchenne myopathy early onset... Read More